Associations between adiponectin and two different cancers: Breast and colon

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 1, 2012, Pages 395-398

  Gulcelik, Mehmet Ali ^a   Colakoglu, Kadri ^a   Dincer, Halil ^a   Dogan, Lutfi ^a   Yenidogan, Erdinc ^a   Gulcelik, Nese Ersoz ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Adipocytokines; Adiponectin; Adipose tissue; Breast cancer; Colon cancer; Obesity

Indexed keywords

ADIPONECTIN;

ADULT; AGED; ARTICLE; BLOOD; BODY MASS; BREAST TUMOR; CASE CONTROL STUDY; COLON TUMOR; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; INSULIN RESISTANCE; MALE; MENOPAUSE; MIDDLE AGED; OBESITY; PROGNOSIS; RISK FACTOR;

ADIPONECTIN; ADULT; AGED; BODY MASS INDEX; BREAST NEOPLASMS; CASE-CONTROL STUDIES; COLONIC NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INSULIN RESISTANCE; MALE; MENOPAUSE; MIDDLE AGED; OBESITY; PROGNOSIS; RISK FACTORS;

EID: 84864876198     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.1.395     Document Type: Article

References (33)

1. Arditi JD, Venihaki M, Karalis KP, et al (2007). Antiproliferative effect of adiponectin on MCF7 breast cancer cells: a potential hormonal link between obesity and cancer. Horm Metab Res, 39, 9-13.
2. Arita Y, Kihara S, Ouchi N, et al (1999). Paradoxical decrease of an adipose specific protein, adiponectin in obesity. Biochem Biophys Res Commun, 257, 79-83.
3. Brakenhielm E, Veitonmaki N, Cao R, et al (2004). Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cellapoptosis. Proc Natl Acad Sci USA, 101, 2476-81.
4. Chandran M, Phillips SA, Ciaraldi T, et al (2003). Adiponectin: more than just another fat cell hormone? Diab Care, 26, 2442-50.
5. Chen DC, Chung YF, The YT, et al (2006). m Serum adiponectin and leptin levels in Taiwanese breast cancer patients. Cancer Lett, 237, 109-14.
6. Dal Maso L, Augustin LS, Karalis A, et al (2004). Circulating adiponectin and endometrial cancer risk. J Clin Endocrinol Metab, 89, 1160-3.
7. Dieudonne MN, Bussiere M, Dos Santos E, et al (2006). Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells. Biochem Biophys Res Commun, 345, 271-9.
8. Fujisawa T, Endo H, Tomimoto A, et al (2008). Adiponectin suppresses colorectal carcinogenesis under the high-fat diet condition. Gut, 57, 1531-8.
9. Fukumoto J, Otake T, Tajima O, et al (2008). Adiponectin and colorectal adenomas: Self Defense Forces Health Study. Cancer Sci, 99,781-6.
10. Goktas S, Yilmaz MI, Caglar K, et al (2005). Prostate cancer and adiponectin. Urology, 65, 1168-72.
11. Grossmann ME, Nkhata KJ, Mizuno NK, et al (2008). Effects of adiponectin on breast cancer cell growth and signaling.Br J Cancer, 29, 370-9.
12. Hu E, Liang P, Spiegelman BM (1996). AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem, 3, 10697-703.
13. Ishikawa M, Kitayama J, Kazama S, et al (2005). Plasma adiponectin and gastric cancer. Clin Cancer Res, 11, 466-7.
14. Kang JH, Yu BY, Youn DS (2007). Relationship of serum adiponectin and resistin levels with breast cancer risk. J Korean Med Sci, 22, 117-21.
15. Karaduman M, Bilici A, Ozet A, et al (2007). Tissue levels of adiponectin in breast cancer patients. Med Oncol, 24, 361-6.
16. Kelesidis I, Kelesidis T, Mantzoros CS (2006). Adiponectin and cancer: a systematic review. Br J Cancer, 94, 1221-5.
17. Kim AY, Lee YS, Kim KH, et al (2010). Adiponectin represses colon cancer cell proliferation via adipoR1- and -R2-mediated AMPK activation. Mol Endocrinol, 24, 1441-52.
18. Kumor A, Daniel P, Pietruczuk M, et al (2009). Serum leptin, adiponectin, and resistin concentration in colorectal adenoma and carcinoma (CC) patients. Int J Colorectal Dis, 24, 275-278.
19. Mantzoros C, Petridou E, Dessypris N, et al (2004). Adiponectin and breast cancer risk. J Clin Endocrinol Metab, 89, 1102-7.
20. Matsuzawa Y, Funahashi T, Nakamura T (1999). Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocyte derived bioactive substances. Ann N Y Acad Sci, 892, 146-54.
21. Miyoshi Y, Funahashi T, Kihara S, et al (2003). Association of serum adiponectin levels with breast cancer risk. Clin Cancer Res, 9, 5699-704.
22. Okamoto Y, Kihara S, Ouchi N, et al (2002). Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation, 106, 2767-70.
23. Otake S, Takeda H, Suzuki Y, et al (2005). Association of visceral fat accumulation and plasma adiponectin with colorectal adenoma: evidence for participation of insulin resistance. Clin Cancer Res, 11, 3642-6.
24. Petridou E, Mantzoros C, Dessypris N, et al (2003). Plasma adiponectin concentrations in relation to endometrial cancer: a case-control study in Greece. J Clin Endocrinol Metab, 88, 993-7.
25. Schlienger JL, Luca F, Vinzio S, et al (2009). Obesity and cancer. Rev Med Interne, 30, 776-82.
26. Sugiyama M, Takahashi H, Hosono K, et al (2009). Adiponectin inhibits colorectal cancer cell growth through the AMPK/mTOR pathway. Int J Oncol, 34, 339-44.
27. Takahata C, Miyoshi Y, Irahara N, et al (2007). Demonstration of Adiponectin Receptors 1 and 2 mRNA expression in human breast cancer cells. Cancer Lett, 250, 229-36.
28. Tian YF, Chu CH, Wu MH, et al (2007). Anthropometric measures, plasma adiponectin, and breast cancer risk. Endocr Relat Cancer, 14, 669-677.
29. Tworoger SS, Eliassen AH, Kelesidis T, et al (2007). Plasma adiponectin concentrations and risk of incident breast cancer. J Clin Endocrinol Metab, 92, 1510-6.
30. Wei EK, Giovannucci E, Fuchs CS, et al (2005). Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study. J Natl Cancer Inst, 97, 1688-94.
31. Weyer C, Funahashi T, Tanaka S, et al (2001). Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab, 86, 1930-5.
32. Wolk A, Gridley G, Svensson M, et al (2001). A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control, 12, 13-21.
33. Yamauchi T, Kamon J, Ito Y, et al (2003). Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature, 423, 762-9.